Raymond James & Associates’s US Physical Therapy USPH Stock Holding History

Raymond James & Associates’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.61M	Buy	19,011 +980	+5%	+$87K	﹤0.01%	2362
2024 Q2	$1.67M	Buy	18,031 +1,212	+7%	+$123K	﹤0.01%	2272
2024 Q1	$1.9M	Buy	16,819 +1,120	+7%	+$112K	﹤0.01%	2190
2023 Q4	$1.46M	Buy	15,699 +3,468	+28%	+$305K	﹤0.01%	2287
2023 Q3	$1.12M	Sell	12,231 -499	-4%	-$53.6K	﹤0.01%	2385
2023 Q2	$1.55M	Buy	12,730 +3,654	+40%	+$394K	﹤0.01%	2220
2023 Q1	$889K	Buy	9,076 +2,358	+35%	+$225K	﹤0.01%	2520
2022 Q4	$544K	Buy	6,718 +1,065	+19%	+$89.3K	﹤0.01%	2847
2022 Q3	$430K	Buy	5,653 +2,300	+69%	+$221K	﹤0.01%	2954
2022 Q2	$366K	Buy	3,353 +548	+20%	+$58.2K	﹤0.01%	3100
2022 Q1	$279K	Buy	+2,805	New	+$268K	﹤0.01%	3461

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James & Associates's USPH Position: Q3 2024 in Review

Raymond James & Associates increased its US Physical Therapy (USPH) stake by 5.4% in Q3 2024, buying an estimated $87K and bringing the position to 19,011 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2362.

Raymond James & Associates first reported a position in USPH in Q1 2022 and has held it in 11 quarters since. The position peaked at $1.9M in Q1 2024. 257 funds tracked by Wall St. Rank hold USPH as of Q3 2024.

Raymond James & Associates held 19,011 shares of US Physical Therapy worth $1.61M as of Q3 2024.
Raymond James & Associates bought 980 US Physical Therapy shares in Q3 2024, an estimated $87K.
US Physical Therapy made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2362 holding.
Raymond James & Associates first reported a position in US Physical Therapy in Q1 2022 and has held it in 11 quarters since.
Raymond James & Associates's US Physical Therapy position peaked at $1.9M in Q1 2024.
257 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.